Snovitra Super Power
Dapoxetine is a short-acting SSRI drug for the treatment of premature ejaculation in men. Dapoxetine is the only drug with regulatory approval for such treatment. Currently, it is approved for use in several European countries including Finland, Sweden, Portugal, Austria and Germany. Dapoxetine is also being considered for approval in other European countries and in the United States where it is currently in Phase III of the Food and Drug Administration (FDA) approval process.
Research has shown dapoxetine to have a benefit in the treatment of premature ejaculation. In a report published in the 'British Journal of Urology' based on data from the phase III trail authors conclude that dapoxetine is well tolerated and found to improve all variables associated with premature ejaculation including reduction of personal distress, interpersonal difficulty and improvement in the satisfaction with the sexual intercourse.
When a man becomes aroused the arteries in the penis relaxes and widen allowing more blood to flow in and the penis to harden. When the erection is no longer needed an enzyme called PDE-5 starts a process which results in the arteries to harden and the blood to flow out of the penis taking it back to its normal state.
PDE-5 is naturally occurring in the penis during the erection. In men suffering from inadequate erectile function, suppressing the action of PDE-5 will help the patient achieve and maintain an erection.
Vardenafil works by specifically targeting the action of PDE-5. This has been proven to increase the erectile function in patients suffering from erectile dysfunction almost regardless of the cause.
How to take Snovitra Super Power
Snovitra Super Power is taken orally and will start working after app. 1 hour after intake. It will continue to inhibit PDE-5 for up to 5 hours.
Snovitra Super Power is clinically proven to work
Snovitra Super Power has undergone several clinical studies to test its ability to help patients suffering from erectile dysfunction. Vardenafil has also been tested for with specific groups of patients such as diabetes.